Healthcare is in the midst of a digital revolution, unlike anything the industry has experienced before. But, according to CHIME CEO Russell Branzell, the growing dependence on technology for patient care and remote work is raising concerns related to cyberattacks.
Sesame, a startup building a cash-pay marketplace for healthcare, raised $24 million. The sudden adoption of telehealth by the broader public led the startup to grow faster than expected.
Vaccitech and Werewolf Therapeutics joined the public markets, raising a combined $230 million. The vaccine developer and the cancer immunotherapy biotech will apply the IPO proceeds toward clinical development of their respective pipelines.
The science of using sensor data to define, measure, and create mathematical models of disease can lead to better outcomes—and huge benefits—for everyone in healthcare and life sciences.
Read about new developments from Seven Bridges, Blue Therapeutics, Outcomes4Me and more.
Executives at large companies feel that the cost of providing employee health benefits will become unsustainable within the next decade, a new survey shows. They want the government to play a bigger role in providing coverage and lowering costs.
Patients are not the only ones who will benefit from the price transparency rule — providers and payers can also gain competitive advantages as a result of the regulation. These include being able to deepen relationships with patients and support payment contract negotiations.
The company launched CVS Health Ventures, a corporate venture fund that will make early investments in healthcare startups. It will start with a $100 million fund.
The list of FDA-approved antibody drug conjugates (ADC) is growing, and two more biotech startups have emerged from stealth with new cash and new approaches to this type of cancer drug. Adcendo and Adcentrx raised a combined $112 from their Series A financings.
The greatest uncertainty is members’ health status, which could impact MA organizations’ bidding submission process for 2022. Fortunately, fully vaccinated members are likely to resume in-person care this year, which means MA plans can expect a more consistent and reliable stream of data to form… Read More »Top 5 Medicare Advantage plan changes coming for 2022
Capsule, an online pharmacy startup that offers same-day prescription delivery, raised $300 million in funding. It plans to use the funds to build out an online marketplace for digital health solutions.
Adverum Biotechnologies reported that a diabetic macular edema patient treated with the biotech’s experimental gene therapy developed complications, including blindness, in the treated eye. The company has unmasked the study and is trying to identify potential risks to other patients.
While the long-term impacts of Covid-19 are still unfolding, here are four ways hospitals and health systems are beginning to understand the monumental impact of the pandemic on the healthcare industry.
After initially purchasing a 40% stake in Kindred at Home for $2.4 billion in 2018, Humana is now fully acquiring the home health and hospice provider for an additional $5.7 billion. The provider will transition to Humana’s payer-agnostic healthcare services brand CenterWell.
Boundless Bio’s research has uncovered a previously unknown driver of cancer growth and drug resistance. With $105 million in Series B financing, the biotech is on a path to bring to the clinic small molecules that address this target, called extrachromosomal DNA.
Insurer Cigna plans to cover mental health startup Ginger’s coaching services as a covered benefit. Investors are pouring more funds into mental health startups as they companies and insurers alike look for more ways to meet people’s care needs during a challenging year.
There’s a real opportunity to go beyond a piecemeal, bare-minimum, “check-the-box” approach and think of FHIR mandates as an opportunity to kick-start consistency across your API landscape.
CMS has released its proposed inpatient payment rule for fiscal year 2022, which includes a payment bump that could increase reimbursement for hospitals by $2.5 billion. Further, in a win for hospitals, the proposal aims to repeal a part of the price transparency rule related… Read More »CMS proposes putting $2.5B into hospitals’ coffers, eliminating part of price transparency rule
Kaia Health, a startup providing app-based programs for musculoskeletal conditions and COPD, recently raised $75 million in funding. As competitors look to round out their platforms with other services, Kaia is looking to strike partnerships with clinicians.
To even approach the level of sophistication at which package delivery, ride-sharing and airline companies operate, health systems must employ modern tools to help.
Amplyx Pharmaceuticals brings Pfizer a clinical-stage antifungal candidate with a novel mechanism of action. The pharmaceutical giant is trying to build its antifungal product lineup, which is currently led by a drug that has lost patent protection.
For years, many Americans have struggled to afford basic healthcare. The Covid-19 pandemic has exacerbated […]
Learn from our expert panel as they discuss the challenges and opportunities of value-based contracting.
Learn from payers focused on health tech, medical device investors and others on what investment trends to watch for this year.
Renovia, a digital health startup that developed an app-based program for urinary incontinence, raised $17 million in funding. The company recently completed a clinical trial that it plans to share with insurance carriers as evidence of its efficacy.
Seasonal allergy sufferers have a plethora of choices for treating the itching and redness affecting their eyes. An experimental Aldeyra Therapeutics drug that takes a new approach to blocking inflammation triggered by allergens has met the goals of a pivotal study and the biotech now… Read More »No more tears: Aldeyra’s eye drug data support its allergy treatment alternative
The problem is that we’re approaching technology from a clinical and billing perspective, with little input from patients. We must demand and implement technology that is designed for the population you are serving.
The government’s proposed changes to HIPAA aim to provide guardrails against data breaches and misuse, but some of the modifications may not work as intended. Three healthcare experts delved into the ways in which certain proposals could provide inappropriate access to health data during a… Read More »Some proposed HIPAA changes could inadvertently expose the data it’s supposed to protect
The physician practice management company launched its IPO through which it plans to sell 19.5 million shares of common stock, priced between $17 and $19 per share. It will use the proceeds for general corporate purposes, like research and development, and to acquire complementary businesses… Read More »Privia Health launches IPO, aims to raise up to $370M
Mobile carriers like Verizon and T-Mobile are dipping their toe into telehealth through partnerships and acquisitions. Earlier this month, Verizon rolled out a telehealth platform based on video conferencing software BlueJeans
Several companies are developing immunotherapies targeting the “don’t eat me” cancer protein CD47. Arch Oncology, which is developing drugs with features that could set them apart from the field, now has $105 million for multiple clinical trials.
Too many cold chain suppliers are still monitoring deliveries and storage compliance with paper-based documentation by individuals scanning thermometers every two hours. Such systems fall short of 21st-Century requirements for biologic medicine.
Bright.MD’s approach to virtual care seeks to make patient encounters more productive, improve patient satisfaction and help providers deliver care more efficiently. Presbyterian Healthcare Services offers a case study.
Virta Health, a digital health startup with an app-based coaching program for type 2 diabetes, raised $133 million led by Tiger Global. Unlike other digital health companies, Virta builds its program around a ketogenic diet.
Learn how health systems and health plans are addressing care gaps with minorities and what strategies are being utilized to close those gaps.
The company is planning to use the newly raised funds to scale its remote patient monitoring solution, which integrates data from wearables and patient-reported symptoms to give clinicians a virtual view into patients’ health at home. The company’s plans also include doubling its workforce this… Read More »Current Health nabs $43M to scale remote patient monitoring solution
Plant-based drug discovery may be tens of thousands of years old, but in 2021, it feels exciting, rich, and full of potential. Companies are rapidly building scalable databases with hundreds of thousands of unique chemicals and their links to biological signatures.
The finalists across health IT, biopharma, medical devices, diagnostics, and health services tracks were judged on criteria that included: completeness of overall plan, business idea, market opportunity, revenue model, and founder(s) experience.
The California-based health system agreed to settle two lawsuits alleging unfair practices that resulted in Black and Hispanic workers being paid less and receiving fewer promotions than their white counterparts. In total, Kaiser Permanente agreed to pay $18.9 million as part of the settlements.
A uniQure gene therapy for hemophilia B that has been under a clinical hold for four months can now resume testing. The hold was lifted after uniQure answered the FDA’s questions about whether the gene therapy caused the liver cancer diagnosed in one patient who… Read More »FDA lifts clinical hold, clearing uniQure to resume hemophilia gene therapy trial
Healthcare companies had another record-breaking quarter, according to CBInsights. They raised a total of $31.6 billion in the first quarter, including big investments in telehealth and health IT.
With patients being granted easier access to their data, and thus greater and more informed agency over their health, we are finally opening the door for insights to be derived and refined on their behalf
With FDA approval of Zynlonta, ADC Therapeutics can offer patients who have diffuse large B-cell lymphoma an option if CAR-T therapy doesn’t work. Additional clinical trials are underway that could expand use of the antibody drug conjugate to more cancer patients.
Alnylam Pharmaceuticals has filed for FDA approval of vutrisiran, which could become the biotech’s fourth drug that works by RNA interference. Meanwhile the company is responding to a federal subpoena seeking documents related to the company’s marketing and promotion of its first RNAi drug, Onpattro.
As researchers and clinicians understand and embrace the advanced insights genetic and genomic testing can deliver, the industry is poised to dramatically reduce the incidence and mortality associated with cancers.
The Blue Cross Blue Shield Association recently announced its new national health equity strategy that will focus on maternal health, diabetes, cardiovascular care and mental health. The association’s first goal is to cut racial disparities in maternal health by 50% in the next five years.
The digital health company filed a complaint with the Federal Trade Commission last week, seeking a ban on the import of the Apple Watch. AliveCor cited copyright violations related to Apple’s ECG feature as the reason for seeking the ban.
Covid-19 showed how technology can upend the old ways of clinical trials. Panelists at MedCity’s INVEST conference said it’s highlighting the importance of improving clinical trial diversity so that tests of new therapies and vaccines reflect the population of patients that they will treat in… Read More »Covid-19 serves as catalyst for effort to diversify clinical trial enrollment
If satisfying emotional needs allows one doctor to improve the life of one patient, imagine what a winning product can do for millions of them.
The five life sciences IPOs this week continues the steady march companies are making to the public markets this year. This week’s activity follows a first quarter that Renaissance Capital calculates was the busiest for newly public companies since 2000. Healthcare IPOs continued to dominate… Read More »Biotech and medical device companies raise $913M in a five-IPO week
Care navigation startup Accolade struck an agreement to buy telehealth startup PlushCare for $450 million. The goal is to support primary care physicians with information about a patient’s health and benefits, CEO Rajeev Singh said.
Healthcare staff are working through immense loss, grief and uncertainty to provide care during the Covid-19 pandemic. As organizations think about how to support their staff, speakers at a MedCity INVEST panel said they must first talk about it openly and provide a safe space… Read More »To help tackle healthcare worker burnout, start talking about it
New recommendations may provide reassurance for patients and their care teams, while uniquely positioning healthcare providers to help communicate this critical information to vulnerable populations.
The FDA approved GlaxoSmithKlie drug dostarlimab (Jemperli) for endometrial cancer that carries a particular genetic signature. The immunotherapy now joins Merck’s Keytruda as the checkpoint inhibitors approved for treating endometrial cancer.
Dr. Micky Tripathi on interoperability, health equity & how his work with VCs will help him lead the ONC
In a wide-ranging interview, the National Coordinator for Health IT Dr. Micky Tripathi discussed his career and how his varied experiences have expanded his perspective. He also spoke about ONC’s plans for the future, which include “evangelizing” about the opportunities the federal interoperability rules will… Read More »Dr. Micky Tripathi on interoperability, health equity & how his work with VCs will help him lead the ONC
Seqster, a San Diego based company looking to build a platform for patients’ health records, DNA data and wearable data, raised $12 million in a funding round led by OmniHealth Holdings.
After the Federal Communications Commission awarded $200 million to help healthcare providers purchase telehealth equipment, more than half of the awards went to equipment for providers and staff at clinics and hospitals. Just a quarter of awards were to help patients overcome the digital divide.… Read More »More than half of FCC telehealth awards went to equipment for providers
Value-based contracts covering the reimbursement of drugs and medical devices are slowly gaining acceptance. A panel at the MedCity News INVEST conference discussed the challenges and opportunities for these contracts, which aim to improve patient outcomes and control the cost of care.
The health insurance technology company has raised $15 million in a Series A funding round. It will use the funds to expand access to its supplemental health plan nationwide and engage in new partnerships.
Vertex Pharmaceuticals is collaborating with Obsidian Therapeutics to develop up to five new gene editing therapies. Obsidian’s technology precisely controls protein expression, a capability the partners plan to apply to several undisclosed serious diseases.
As part of MedCity’s 2021 INVEST conference, Cesar de la Fuente, presidential assistant professor at the University of Pennsylvania, explains the value of the rapid low-cost diagnostic test he has developed to detect SARS-CoV-2 and how the platform technology can be deployed to detect other… Read More »MedCity Spotlight Video: How Penn Center for Innovation is combating Covid-19 [Sponsored]
Unless the Supreme Court strikes down the ACA, it will remain in place for the foreseeable future and will see expansion.
In response to emailed questions, the CEO and CTO talk about the immune intelligence startups’ Human Immunity Map — a growing database of immune interactions that can support the development of multiplex diagnostics, vaccines and therapeutics.
With new viral variants reported across the globe, this evolving pandemic requires clinicians to explore novel ways to assuage patient fears about Covid vaccines.
In the final days of the Trump Administration, the Department of Health and Human Services sought to deregulate 83 different types of medical devices, citing a lack of reported adverse events. But the Food and Drug Administration put an end to the sudden reversal, saying… Read More »HHS reverses previous administration’s push to deregulate more than 80 medical devices
MedCity Spotlight Video: JPMorgan executive provides insight into healthcare investment trends [Sponsored]
Skip Kelly, a managing director at J.P. Morgan provides a broad overview of how the healthcare investment landscape is shaping out in the midst of a historic pandemic.
The provider and payer are launching a new company that will focus on advancing value-based care. The for-profit joint venture aims to leverage the organizations’ data and expertise to create new care models, solutions and payment strategies.
The Covid-19 pandemic pushed the already impressive growth in healthcare investing to new heights, with valuations on the rise and companies gaining access to vast sums of money. But speakers at a MedCity INVEST panel warned that raising more capital than needed is not always… Read More »Investment in healthcare is soaring, but entrepreneurs must be wary of over-capitalizing
Of 26 health systems surveyed by MedCity News, nearly half used automated tools to respond to the Covid-19 pandemic, but none of them were regulated. Even as some hospitals continued using these algorithms, experts cautioned against their use in high-stakes decisions.
Biotech startup Janux Therapeutics has a technology that selectively and safely directs T cells to strike cancer cells and an R&D partnership with Merck. Now it has $125 million in Series B financing as it joins the chase to bring these T cell engager drugs… Read More »Stealthy biotech Janux nabs $125M and joins chase to direct T cells to solid tumors
The pandemic has highlighted longstanding disparities in how people access mental healthcare. But as more people and policymakers focus on mental health, will this change?
The California-based provider has filed a lawsuit against the payer, claiming Anthem has yet to pay for the care it provided to patients covered by its affiliate. Stanford and Anthem had an implied contract, and if it is not upheld by the court, the provider… Read More »Stanford Health Care seeks up to $1.9M from Anthem in new suit
The FDA placed a clinical hold on a KalVista Pharmaceuticals drug being readied for mid-stage studies in a rare, inherited disorder. Meanwhile, the FDA has some questions about the historical data Y-mAbs used as the control in a clinical trial for its antibody cancer drug.
Vertex Pharmaceuticals is amending its collaboration with CRISPR Therapeutics, paying $900 million now for chance to grab a bigger share of a gene-editing therapy’s profits later—if the treatment is approved. Clinical trials evaluating the CRISPR-based therapy are underway in sickle cell disease and beta thalassemia.
After insurers were mandated to cover at-home Covid-19 tests, more people tested at-home screenings for other conditions. As preventive tests declined significantly during the pandemic, insurers also turned to creative means to give people access.
The Illinois-based health system is teaming up with the analytics company to launch a genomics program, which will focus on predicting the risk of illness and outcomes among patients. It will also provide free genetic testing to low-income patients in an effort to increase access… Read More »NorthShore, Sema4 set up genomics program to advance personalized treatment
McKesson Ventures is one of the most active investors in the biopharma software sector with Komodo Health, Evidation and M2Gen among its portfolio companies.
After the Food and Drug Administration authorized a swathe of over-the-counter tests for Covid-19, pharmacies are preparing to stock their shelves. But at $20 to $100 a pop, will enough people use them to make a difference?
It is clear that virtual care is here to stay, but it is not the availability of technology that will govern how care is delivered. Rather, patients’ preferences, along with their underlying social needs, will determine which care delivery strategy providers need to use to… Read More »Virtual care’s popularity notwithstanding, patient preference will still drive healthcare delivery
Tomorrow Health, a startup looking to streamline the process of getting medical equipment and supplies for home care, raised $25 million in funding led by Andreessen Horowitz.
Antibody therapies are seen as one way to overcome the variants that continue to fuel the pandemic. With its Series C financing, Adagio Therapeutics, led by CEO Tillman Gerngross, will proceed with a pivotal clinical trial of an antibody that has neutralized SARS-CoV-2 variants in… Read More »Adagio adds $336M for pivotal tests of drug with potential to beat Covid variants
Providers, payers are ready to listen, root out racism and regain the trust of minorities. Here’s how.
Racism has always existed in healthcare, but the Covid-19 pandemic laid bare how entrenched the problem still is. In response, providers and payers have vowed to fight for health equity by examining the racism within their organizations, listening to minority communities and mounting strategies that… Read More »Providers, payers are ready to listen, root out racism and regain the trust of minorities. Here’s how.
The volume of calls to hospital call centers has led to an industrialized approach thereby sacrificing the human touch and personal connection between doctors and patients. Ironically, artificial intelligence can help to rekindle that by handling call center calls more efficiently.
Despite a 20-year head start, providers still fall short of HIPAA requirements around fulfilling patient requests for their medical records. In light of the federal information blocking rules, providers should first examine their compliance with HIPAA and then address the new demands imposed by the… Read More »Compliance with HIPAA may offer some clues on how providers will fare with new info blocking rules
Incubated by OribMed and led by Ariad Pharmaceuticals veterans, Theseus Pharmaceuticals unveiled $100 million in Series B financing to develop the next generation of tyrosine kinase inhibitors, a type of cancer drug. The company expects to enter the clinic by the end of 2021.
The Texas-based health system first sued the staffing firm for “price gouging” amid the Covid-19 pandemic, as wages for nurses shot up from $75 to $160. But the firm countersued, claiming that Steward — which owes Aya over $40 million — previously did not raise… Read More »Steward Health v Aya Healthcare: 4 things to know
AI, therapeutics for autoimmune diseases, automation for biomedical research and oncology are among the areas of interest for the finalists in the biopharma track scheduled for day two of the conference.
These innovations have not only made medical check-ups safer, but they’ve also helped modernize and improve the patient journey. These technologies automated many archaic administrative functions and offered medical practices genuine savings – in terms of both time and money.
Relay Therapeutics has its own technology that applies artificial intelligence and machine learning techniques to drug discovery. Its $85 million acquisition of ZebiAI gives it another technology that applies ML to DNA-encoded libraries and predicts the small molecules with the potential to drug proteins.
Serimmune has enrolled more than 2,000 participants in a clinical study designed to understand the human immune response to the virus that causes Covid-19. Also, news from Legacy, Tomorrow Health, and more.
As a country, we must do a better job supporting people and communities throughout their health journey because communities with greater access to information and increased levels of health literacy will ensure better health outcomes.
Together, the Tennessee-based health system and health technology company will develop solutions to help clinicians detect diseases faster. The new agreement builds on an existing partnership that focuses on earlier diagnoses for lung cancer.
As telehealth becomes mainstream, seniors will be forced to adapt – but we as healthcare providers have a duty to make this process as seamless as possible, so one of our most vulnerable populations does not get left behind.
Merck is discontinuing work on one Covid-19 drug for treating hospitalized patients after the FDA said it needs more clinical data. Another Merck drug candidate is moving forward only in outpatient testing after independent clinical trial observers concluded the antiviral was unlikely to help those… Read More »Merck’s Covid-19 drug R&D falls short twice in treating hospitalized patients
Thermo Fisher Scientific sells laboratory equipment used in drug research and it also offers manufacturing services for experimental and commercialized drugs. By acquiring PPD, Thermo Fisher says it will gain capabilities in the growing global market of clinical trial services.
These next few months are a tremendous opportunity to build trust with customers — imagine the reciprocal goodwill if a payer’s message helps its members get to the front of the line.
The new joint venture will bring K Health’s artificial intelligence-driven technology to the consumer, employer and insurer markets. The solution enables patients to understand their symptoms and connect with a doctor if needed.
President Joe Biden has submitted his discretionary budget for 2022 to Congress. Among its healthcare provisions are funding requests for the CDC, mental health and social determinants of health programs. But there are some unusual requests as well, such as funding for an Office of… Read More »Public health, racial equity, climate action drive Biden’s budget requests for healthcare
Amylyx’s ALS drug met the goals of a mid-stage study, paving the way for regulatory submissions in Europe and Canada. But the FDA is requiring data from a larger Phase 3 clinical trial and that study is slated to begin later this year.
Digital health startup Omada is adding virtual consultations with physicians to its platform. To start, the company is offering physician-guided care for diabetes and hypertension.
Livongo’s founder has created a new care navigation venture because he believes that both the experience that people undergo as they look for care and the level of risk that vendors are willing to take when they work with self-insured employers leave much to be… Read More »In MedCity Pivot podcast, Glen Tullman says other care navigation firms aren’t really taking risks
Research conducted by the Cleveland Clinic and Massachusetts-based startup Health Data Analytics Institute (HDAI) measured the difference in mortality during the pandemic between people covered by Medicare in long-term care facilities and in the community. While a Covid-19 diagnosis increased deaths in both settings, there… Read More »Cleveland Clinic researchers measure pandemic’s effect on Medicare population
In order to gain insight into how organizations are thinking about digitizing medical documents and the strategy behind those decisions, we’re conducting a brief survey of the MedCity News audience and will publish a report based on this survey’s findings.
There should be a discussion about how to address the disproportionate impact Covid-19 has had on Black communities.
Tango Therapeutics’ SPAC merger will infuse the biotech with $353 million to fund clinical trials for its cancer drugs based on synthetic lethality. Tango’s lead program is on track to reach the clinic next year.
Mayo Clinic struck joint ventures with two startups to develop and commercialize AI diagnostic tools. It’s part of a broader plan by Mayo Clinic to develop more AI tools to support clinical decisions.
In a review of 130 FDA-cleared AI tools, researchers found that the vast majority of them relied on retrospective studies. Most of the developers also didn’t share information on how many sites the algorithms had been tested in, or how they performed in different patient… Read More »FDA-cleared AI devices lack critical information on performance, equity
As part of its ongoing effort to improve maternal outcomes in the country, the government has approved Illinois’ request to extend full Medicaid coverage for new mothers. The approval extends the coverage from 60 days to one year and will give about 2,500 women living… Read More »Illinois first state to offer full Medicaid benefits to women one year postpartum
Blood clots found in six people given Johnson & Johnson’s Covid-19 vaccine have led federal health officials to recommend a pause on dosing with that shot. A CDC advisory committee on vaccine practices is meeting Wednesday to review the cases, which so appear similar cases… Read More »FDA & CDC “pause” J&J Covid-19 vaccine to launch inquiry into rare blood clot cases
Though the price transparency rule aims to make it easier for healthcare consumers to compare prices, there is a lack of standardization in how hospitals present the data, making it hard for consumers to shop around for care, a new analysis shows.
Surgical retractor systems, catheters, minimally invasive surgery, wireless power transfer technology, microwave ablation, and jaundice treatment are among the areas the six medical device finalists cover.
Cellino Biotech CEO and Co-founder Dr. Nabiha Saklayen talked about the formation of the company and its goal to make stem cell therapies accessible for patients.
No matter if Democrats or Republicans are running the show in Washington, here are three solid bets for pharma companies to plan for in the changing drug-pricing landscape
With two cancer programs already making progress, Repertoire Immune Medicines will use the Series B financing to expand its immune synapse research to autoimmune disorders and infectious disease. CEO John Cox said his startup’s approach could advance immune medicines beyond the scope of currently available… Read More »Biotech startup Repertoire adds $189M to expand array of immune medicines
Covid-19 was a lightning rod for life science deals last year. What investment trends are taking shape in 2021? [Sponsored]
Peter Meath, Co-Head of Healthcare and Life Sciences for Middle Market Commercial Banking at J.P. Morgan, is bullish that the momentum will continue, particularly with investment trends focused on pain points amplified by the Covid-19 pandemic, from diagnostics development to supply chain management.
Cohere Health raised $36 million in a Series B funding round less than two years after its inception. It will use the new funds to expand its prior authorization platform and integrate health plan benefits to eliminate missed opportunities for care.
Though the number of merger and acquisition deals in the first quarter of 2021 fell below historical averages, the size of the deals was far bigger than the same period last year, a new report from Kaufman Hall shows. The total transacted revenue was $8.8… Read More »Report: Fewer health system M&A deals in Q1 2021 offset by larger transactions
Canvas Medical, a startup looking to build electronic medical records and ancillary tools for primary care systems, raised $17 million in funding.
A Regeneron Pharmaceuticals antibody cocktail currently authorized for treating Covid-19 now has additional clinical data showing it reduces the risk of infection spread. The drug developer, along with partner Roche, plan to ask regulators to expand the drug’s authorization to include disease prevention.
Microsoft will buy up healthcare AI partner Nuance for $19.7 billion. Nuance makes speech-recognition tools for clinical documentation, as well as security tools.
Historically, providers had to meet certain criteria and address three key areas in the patient’s progress notes: patient history, physical exam and medical decision making. CMS has eliminated the history and exam components as required elements for billing purposes, so medical decision making is now… Read More »How CMS final rule will impact E/M coding and documentation requirements
The HHS’ new interoperability and information blocking rules have been in effect for one week, yet how they will be enforced is unclear. But there are some clues that could provide a glimpse into what the enforcement landscape might look like, and the best thing… Read More »Enforcement landscape for HHS data-sharing rules is hazy, experts say
Digital health startup Better Therapeutics plans to go public through a SPAC merger that would value it at $187 million. The company is currently running a pivotal study to see if its app-based program could be used as a treatment for type 2 diabetes.
Sanofi, which already has messenger RNA R&D alliances with other companies, paid $160 million up front to acquire preclinical startup Tidal Therapeutics. The pharma giant said Tidal’s mRNA approach could lead to an off-the-shelf CAR-T therapy.
Fitbit is launching a trial to see if its its newest smartwatch could use pulse arrival time to measure blood pressure. Other wearable companies have tried to add wrist-based blood pressure features to their devices, but so far, they have limited accuracy.
Several healthcare entities that used Accellion’s file transfer software now find themselves the victims of a data breach, including Trinity Health. The software had vulnerabilities that were exploited by cybercriminals, resulting in the exposure of personal health information.
The public markets welcomed VectivBio and Reneo Pharmaceuticals, which priced their IPOs late Thursday. Both clinical-stage companies are developing drugs that address rare diseases.
Creating the simplest process for informed consent benefits the potential participant by allowing them the time and resources to understand fully what they are consenting to. Through eConsent processes, research also opens the door to a more diverse population to engage in trials.
Representatives from five health services startups will present their companies to three judges, followed by a Q&A. The judges for the health services track include: Cheryl Chang of BlueRun Ventures; Keith Figlioli of LRVHealth, and Steve Tolle of HLM Venture Partners.
Though a majority of healthcare workers believe that the pandemic is at least somewhat under control now, about half still feel anxious or burned out when going to work, a new survey shows. Pandemic-related stress has also given rise to physical issues among healthcare workers,… Read More »Poll: About half of healthcare workers feel burned out, anxious when going to work
Global investment firm KKR plans to acquire a majority stake in health software company Therapy Brands. PSG, a previous investor in the company, will remain a minority shareholder.
RA Capital led Ventus Therapeutics’ Series B financing, which the startup will use to develop its pipeline of medicines for “undruggable” disease targets. CEO Marcelo Bigal said the cash also gives Ventus the flexibility to consider an IPO.
As Covid-19 cases started escalating last April, providers in hotspot states, like New York, California and Washington, had to quickly pivot their IT plans. These are some of the decisions that five health IT leaders made — aside from expanding telehealth — that helped their… Read More »The key IT decisions that helped providers survive April 2020
VillageMD, a primary care startup that has Walgreens as a big backer, is reportedly planning to go public. The company has plans to open hundreds of co-located primary care clinics at Walgreens pharmacies.
Mobidiag offers multiplex testing, which is the ability to test for multiple pathogens from a single test sample. Hologic said the acquisition will enable the company to enter the acute care test market, which is projected to grow in a post-pandemic world.
The failure of IBM’s marketing-first approach to clinical AI was entirely predictable, but it didn’t have to be this way. Here’s how AI can be implemented effectively.
If we don’t prioritize solutions now, the healthcare digital divide may present more widespread national and international challenges.
The conference highlights the intersections of technology and life sciences through the prism of precision medicine. The topics at the conference span pediatric innovation in precision medicine, how tech companies are addressing clinical trial challenges, supply chain management, and more.
Virtual primary care startup Firefly Health plans to launch a benefit plan after raising $40 million in new funding. The company currently offers virtual and in-person access to a primary care team.
A European Medicines Agency review concluded AstraZeneca’s Covid-19 vaccine may be linked to cases of blood clots. The regulator directed the company to conduct more studies to learn more but stopped short of recommending other vaccines as alternatives.
Centene has rebutted the accusations made in a sealed lawsuit filed by the Ohio attorney general that accused the insurer of over-billing the state’s Medicaid department. The lawsuit is based on a misunderstanding of how Medicaid billing operates and should be unsealed, Centene said.
Akili Interactive received FDA clearance last year for its game-based digital therapeutic to be used as a treatment for ADHD. Now, the company is testing it to see if it could help people experiencing cognitive dysfunction after Covid-19.
Nonprofit hospitals get substantial tax subsidies with the expectation that they will provide higher levels of charity care to needy patients. But these hospitals spend less on charity care than their for-profit counterparts, a new analysis shows.
Finalists for the diagnostics track at INVEST Pitch Perfect include tests for upper respiratory infections, breast cancer screening, in vitro cellular immunoassays, dysphagia diagnostics, and neuroscience.
We can expect the introduction of novel and groundbreaking technologies that will immensely benefit both the dentists and the patients over the years.
While the Covid-19 pandemic has strained the healthcare industry, this administration has the advantage of being able to leverage everything we have learned over the past year to advance the next generation of value-based care.
RA Capital led the $100 million Series B round of funding for Icosavax, a startup developing vaccines based on virus-like particles. The biotech is preparing for clinical tests of vaccines for respiratory syncytial virus, human metapneumovirus, and SARS-CoV-2.
The drugmaker struck a collaboration agreement with Mass General to use its platform for heart failure and asthma management. The health system plans to launch two pilots of the digital health platform.
Insurance technology startup Bright Health has purchased Zipnosis, which provides telehealth services. Though details of the new transaction are sparse, the acquisition aims to lower healthcare costs and expand access to quality care.
Volastra Therapeutics is developing drugs for cancer metastasis, the cause of the vast majority of cancer deaths. The startup has $44 million in funding and an R&D partnership with Microsoft to develop new digital tools to detect and predict metastasis.
Vaccine hesitancy is still a challenge to providers’ immunization plans. Florida-based AdventHealth is bringing the might of AI technology — specifically machine learning and natural language processing — to combat the issue.
Nadine Peters, chief legal officer of Cota Healthcare, shares her journey to leadership in health data privacy law and policy recommendations for the Biden Administration on achieving health equity through data use and education.
The agency said it had received more than 450 reports of infections or other issues in the last four years from reprocessed urological endoscopes, which are used to view or access the urinary tract. Three patient deaths were associated with these infections.
A group of healthcare stakeholders in Oregon signed a compact that aims to spread advanced value-based payment models across the state. Though it is not legally binding, the agreement sets a target to tie 70% of healthcare payments to value within the next four years.
FDA approval of Supernus Pharmaceuticals drug Qelbree gives attention-deficit hyperactivity disorder patients another treatment option that is not classified as a Schedule II substance. It’s a different formulation of a drug that was first approved in Europe decades ago.
After going public through a SPAC merger last year, SOC Telemed bought acute telemedicine provider Access Physicians for $194 million. The deal is expected to bolster the company’s specialty consults and telemedicine services for hospitals.
U.S. Anesthesia Partners has filed lawsuits against UnitedHealthcare in Colorado and Texas, accusing the payer of forcing it out of network and intentionally interfering with its relationships with providers in those states. But, according to UnitedHealthcare, the lawsuits are an attempt to get the insurer… Read More »Lawsuit: Like a “boa constrictor,” UnitedHealthcare squeezed anesthesia group out of competition
The FDA’s rejection of Nuplazid cited clinical trial results in subgroups of patients. Acadia Pharmaceuticals said the FDA’s decision goes against all feedback the company previously received and amounts to an incorrect way of evaluating dementia patients.
Medical payments platform Inbox Health raised $15 million in series A funding. The company works with third-party billing companies to better communicate with patients and make bills clearer.
AI has already shown tremendous promise for everything from automating patient communication and non-clinical administrative tasks to reducing physician burnout. But realizing that promise more broadly requires AI developers to establish trust with their healthcare users.
Your administration needs to establish a mandate requiring health systems that have data sharing capabilities to share their Covid-19 data in the next eight months. This includes Covid-19 test results, vaccination information, and other critical data.
Digital health startups raised a record-breaking $6.7 billion in the first quarter of 2021. Large funding rounds propelled them past previous months.
A Helius Medical Technologies medical device that stimulates the brain by sending electrical stimulation to the tongue has received FDA clearance for multiple sclerosis patients. The company says its approach could also have applications in other disorders.
As the pandemic rages on, the other major public health crisis in recent history has not ebbed. The opioid epidemic is worsening, but providers have kept their eye on the ball and are continuing their efforts to treat opioid use disorder and curb unnecessary prescriptions.… Read More »How providers are tackling a crisis within a crisis — the opioid epidemic
The deadline for ONC’s final rule on interoperability and information blocking is upon us. The time is past due for health providers, networks, and vendors to evolve their IT infrastructure — and the cloud really is the only way forward.
Dr. Thomas Van Gilder, Walmart’s first chief medical officer, will leave the company in May. Walmart’s head of dentistry, Dr. Roshan Parikh, also left the company. Both had a role in helping design some of the first clinics for Walmart Health.
Insurance startup Bright Health is reportedly planning to raise up to $1 billion in an IPO that will be launched in the second quarter of 2021. The company, which provides several insurance products as well as an IT platform, could be valued at more than… Read More »Report: Bright Health eyes $1B IPO
The Food and Drug Administration gave an emergency use authorization to two more over-the-counter Covid-19 tests that can be used without a prescription. They include Abbott’s BinaxNow test and an at-home test developed by Quidel Corp.
Companies focusing on cancer care, high-risk patients, patient safety, tele-dermatology, mental health and medical billing are among the six finalists.
The FDA increased the maximum number of doses permitted for each vial of Moderna’s Covid-19 vaccine, a change intended to make more doses available. The regulator also authorized storage changes for the vaccines at vaccination sites.
The pandemic has upended virtually every industry, and although many of the impacts are undeniably devastating, negative events can also offer opportunities for positive change, by highlighting existing problems and eliminating roadblocks to new solutions.
Healthcare is becoming increasingly unaffordable, with 18% of Americans saying in a new survey that they would not be able to afford the care they need. Respondents also reported cutting back on other expenses to afford healthcare, including money spent on food and utilities.
IQVIA has acquired Quest Diagnostics’ minority stake in Q2 Solutions, a central laboratory services joint venture the two companies formed in 2015. But Quest will remain a preferred provider of lab testing services under an agreement with Q2.
Though telehealth will continue to account for a large portion of healthcare IT budgets in 2021, there are other technology-based services driving provider interest. These range from cloud deployment to vaccine scheduling solutions as providers navigate the new landscape created by the Covid-19 pandemic.
The two companies plan to open a clinic in Phoenix this fall, and additional locations over the next five years. To start, Tia will offer virtual care services in Phoenix.
Peter Meath, J.P. Morgan Commercial Banking’s Co-Head of Healthcare and Life Sciences, applies lessons from 2020’s remarkable second half and shares insights on what to expect in 2021.
The FDA decision for Tyvaso as a treatment for pulmonary arterial hypertension in patients who have interstitial lung disease is the second approval for the United Therapeutics drug. The additional indication gives the company another way to grow revenue for the drug, which faces generic… Read More »United Therapeutics notches another FDA approval for lung drug
The Achilles Therapeutics IPO comes as several other biotechs make progress developing a type of cancer immunotherapy called a tumor-infiltrating lymphocyte. Clinical-stage Achilles contends its approach could best them all.
The HHS’ information blocking rule goes into effect Monday, and for nearly a year, providers and IT vendors have been racing to prepare. But they have faced several hurdles along the way, including figuring out how to handle scenarios that could make them non-compliant.
The startup, which provides primary care services to Medicaid patients, plans to use the funds to expand into new states and add maternity and pediatrics services lines. It also recently launched a vaccination site in conjunction with the New York Department of Health.
Austin-based software startup Docstation is working to make it easier for pharmacists to strike agreements with physicians that would allow them to provide more patient care. It recently raised $3.1 million in seed funding.
Why start with innovation? Because it’s where the products, tools, solutions, and ideas that will change the status quo are born. Without diversity of thought, experience, and perspective, the end result of innovation only serves those already at the table.
Based on the efficacy and safety data for their Covid-19 vaccine in younger teens, Pfizer and BioNTech plan to ask regulators to expand emergency authorization to include this younger group. The expansion could make the mRNA vaccine available to this age group in time for… Read More »Pfizer & BioNTech report Covid-19 vaccine shows 100% efficacy in kids 12 to 15
With the emergence of smart and connected devices and technologies, CROs and life sciences organizations are able to more easily perform decentralized, virtual clinical trials. Now, industry leaders are on a mission to make the practice of administering decentralized clinical trials the norm.
To maximize patient access to care, policies should be modernized to enable the broader digital health landscape
Only with proper coverage and access to the modern technologies that made their mark during Covid-19 can we truly democratize healthcare and make the promise of digital health available to all.
The family of Dr. Lorna Breen, an emergency physician working on the front lines of the pandemic who died of suicide, is working with Congress to introduce legislation that would make it easier for phyiscians to seek out mental healthcare. At the state level, licensing… Read More »Family of Dr. Lorna Breen pushes for mental health protections for physicians
The Federal Trade Commission is opposing Illumina’s proposed $7.1 billion Grail acquisition, arguing that it will reduce competition for multi-cancer early detection tests. Illumina disagrees with the regulator’s position and will oppose the FTC’s challenge.
Medicare Advantage beneficiaries spend $1,640 less per year on healthcare than those enrolled in traditional fee-for-service Medicare plans, a new report shows. But, despite the difference in savings, satisfaction levels for both types of plans are similar.
Healthcare information exchanges could provide the missing link between providers, payers and community-based organizations working to address social determinants of health. Efforts in Nebraska and Ohio show the ways in which HIEs could advance care coordination and interoperability.
Merck agreed to pay $215 million up front to acquire Alydia Health, a startup that has commercialized a medical device that controls bleeding during childbirth. That product will join the portfolio of Merck spinout company Organon.
Now that trials can happen nearly anywhere, privacy teams and lawyers need to understand how data is collected, stored, managed, disseminated, and ultimately, archived or deleted.
Omega Therapeutics has raised more than $210 million in the past eight months for R&D of medicines that regulate genes. The company’s lead therapeutic candidate addresses a validated but elusive cancer target.
BrightInsight, a startup developing infrastructure to make it easier for companies to make their own health apps, raised $101 million in funding. General Catalyst led the series C round.
The healthcare provider and technology giant have entered into a 10-year partnership that will leverage AI, cloud and quantum computing capabilities to accelerate research. The collaboration will include the first private-sector installation of the IBM Quantum System One.
Crossover Health, a startup offering primary care services for several big tech companies, including Amazon and LinkedIn, raised $168 million in funding.
Evidation, launched as a research app where people can opt into virtual clinical trials, plans to turn some of those insights into digital health programs. The company recently raised $153 million in new funding.
The Washington-based health system has filed a lawsuit against EHR giant Cerner saying it intentionally misrepresented its products and services. Cerner’s systems did not operate as promised, leading to severe cash collection issues at Astria Health and forcing it into bankruptcy in 2019, the suit… Read More »Lawsuit: Cerner systems’ failure drove Astria Health into bankruptcy
UniQure is making a case for lifting a clinical hold on its hemophilia B gene therapy, reporting Monday results of an independent investigation that appear to clear the experimental treatment as the cause of a patient’s cancer.
The FDA has approved a Bristol Myers Squibb cell therapy made by engineering a patient’s immune cells to target a cancer protein called BCMA. The regulatory decision for Abecma in multiple myeloma gives BMS its second approved CAR-T therapy.
A group of inventors at the University of Cincinnati are developing a drone that can be used to conduct virtual visits in patients’ homes. The technology aims to fill the gap in telehealth delivery among those who do not have access to the necessary devices… Read More »Drone in your home? Telehealth makeover underway at Univ of Cincinnati
Contactless check-in is not a new concept. Many consumer-focused industries, such as hospitality, have been utilizing this technology for years — including mobile check-in and checkout, keyless entry, and more — to enhance the guest experience.
Earlier this year, AppliedVR shared results of a pivotal study that it plans to submit to the FDA. It received a breakthrough device designation last year to use its VR platform to treat fibromyalgia and lower back pain.
Regenerative medicine might someday provide replacement organs for transplant patients. But Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine, explained how the technology is already helping in the discovery and testing of drugs.
Advocate Aurora Health has launched a subsidiary focused on making investments in companies that enhance health and wellbeing. The subsidiary has already made its first move, leading a $25 million funding round for a telenutrition provider.
As Amazon starts to roll out its telehealth and pharmacy offerings, most big health systems and insurers don’t yet view it as a threat. But pharmacy benefit managers and vertically integrated payers will be keeping a watchful eye on the company as it starts to… Read More »With telehealth, pharmacy offerings, Amazon starts to encroach on PBMs
Design Therapeutics raised $240 million in the biggest biotech IPO this week. One other rare disease drug developer went public along with two oncology biotechs as the IPO momentum continues.
With the increased reliance on digital technologies, pharma companies’ outreach to healthcare providers needs to be thoughtful, efficient, and respectful. An AI-driven, omnichannel strategy makes this possible by giving every member of customer-facing teams visibility across communications.
Bristol Myers Squibb SVP Ho Sung Cho highlights legacy and ongoing research in protein degradation [Sponsored]
Cho discusses Bristol Myers Squibb’s research efforts in the field of protein degradation to advance potential treatments for a broad range of diseases. In a recent MedCity Pivot Podcast, he also shared insights on his approach to drug discovery, perspectives on dealing with failure, and… Read More »Bristol Myers Squibb SVP Ho Sung Cho highlights legacy and ongoing research in protein degradation [Sponsored]
Read new developments on healthcare startups such as Seven Bridges, Scipher Medicine, Applied VR and more.
A top executive at Chicago-based Loretto Hospital has resigned after controversy surrounding vaccination events held at businesses with close ties to him. Mayor Lori Lightfoot said an independent investigation needs to be conducted.
Founded by scientists behind the technology used in Johnson & Johnson’s Covid-19 vaccine, Leyden Laboratories is developing intranasal medicines intended to stop viruses before they infect the lungs. SARs-CoV-2 is one target, but the startup plans to address many respiratory pathogens.
Tuberculosis is highly infectious and a global problem that Covid-19 has only made worse. Ironically, two legacies of our response to Covid-19 can give us hope. Many health systems now have unprecedentedly large testing and tracing infrastructures that we can use to test for TB.
A new report from the HHS’ Office of Inspector General lays bare the varied challenges hospitals faced in the past year — and continue to face. These range from challenges in healthcare delivery to staffing shortages to shaky finances.
After a busy year, at-home testing company Everlywell is growing through two acquisitions. It bought telehealth practice PWNHealth and another at-home lab testing company.
California Attorney General Xavier Becerra may have won a narrow confirmation to be the Department of Health and Human Services Secretary, but if his past is any indication, his agenda will be bold when it comes to reining in pharma companies, boosting the Affordable Care… Read More »The “biggest thorn in President Trump’s side” is now HHS Secretary. What’s next?
AstraZeneca’s latest efficacy data for its Covid-19 vaccine are down slightly from the 79% it previously reported. The most recent data will form the basis of an application for emergency use authorization, which the company still expects to file with the FDA in coming weeks.
Researchers are investigating whether a built-in race adjustment in spirometers could further exacerbate health disparities caused by the pandemic. The medical device is commonly used to diagnose breathing conditions.
In MedCity Pivot podcast, biopharma researcher talks about protein degradation, recent success tied to Covid-19 [Sponsored]
Ho Sung Cho, senior vice president of Biodiscovery Therapeutics at Bristol Myers Squibb, talks about lessons learned from drug discovery, recent success tied to Covid-19, and how the company is leveraging its expertise in protein degradation to develop novel therapies for blood cancers, solid tumors… Read More »In MedCity Pivot podcast, biopharma researcher talks about protein degradation, recent success tied to Covid-19 [Sponsored]
The partnership between the insurer and EHR giant — announced a year and a half ago — will now focus on streamlining prior authorizations and offering providers enhanced insights about their patients. Ochsner Health will be among the first to implement the new capabilities offered… Read More »Epic-Humana partnership enters new phase focused on prior authorizations
If HIPAA does not apply to Amazon Care, then absent another privacy regulation applying, avoiding exploitation of the data relies on the good faith of the entity operating the service.
Healthcare delivery is one of the themes at the annual MedCity News virtual INVEST conference, April 19-23. Register today!
Medicare sequestration is making headlines this week, as legislation to pause the 2% payment cuts moves through Congress. Here is a recap of what the sequester cuts are, why hospitals want it gone and how lawmakers are working to make that happen.
ProQR Therapeutics has encouraging data from an early-stage study evaluating its treatment for vision loss in the rare, inherited disorder Usher syndrome. The biotech now plans to advance its RNA therapy to two pivotal studies later this year.
Ginger, a startup that connects users with mental health coaches and therapists, raised $100 million in funding. The company is shifting to a risk-based model as it expands.
GSK has terminated Moncef Slaoui as board chair of Galvani Bioelectronics after an investigation substantiated a sexual harassment claim dating to his tenure at the pharmaceutical giant. The company said the inquiry is continuing.
Becoming mired in discussions about public versus private options is not the best avenue, Instead, we can work to make Covid-related state executive orders permanent.
Appriss Health, which provides behavioral health insights to clinicians, plans to purchase care coordination solutions provider PatientPing for an undisclosed sum. The deal is expected to close within the next two months, but the combined company’s first steps are still being decided.
Areas that have been hit hardest by the Covid-19 pandemic are falling short when it comes to vaccine access. Community leaders are pushing to bring vaccination sites to their neighborhoods.
Ro, a direct-to-consumer health startup, recently raised a $500 million funding round. It plans to use the funds to expand into at-home diagnostics and care.
A new digital health company — spun out from Providence’s Digital Innovation Group — has raised $20 million in its first funding round. The company offers a platform that aims to help providers coordinate and manage digital care services.
Federal health authorities say safety observers are concerned AstraZeneca did not release complete information about the efficacy of its Covid-18 vaccine. The company responded by saying its data were from a pre-specified analysis and it will provide the most up to date efficacy data within… Read More »AstraZeneca’s Covid-19 vaccine data may have ‘outdated information,’ NIH cautions
The emergence of new approaches to the coordination and delivery of behavioral health services is long overdue. Evaluating their impact on some of the most complex and interconnected areas of medicine will require time and work.
Healthcare must move toward a circular economy, and single-use device reprocessing offers a template to follow
In healthcare, the linear (take-make-dispose) approach to consumption is even more pronounced than in American culture in general. It’s time for change.
Interluekin-2’s use as an immunotherapy has been limited by its severe side effects. Asher Bio is developing a version of IL-2 that the startup’s Chief Technology Officer Andy Yeung said could be more targeted and safer than other approaches.
Private equity firm Accelmed recently closed an oversubscribed, $400 million fund. The firm primarily invests in health-tech startups, such as its recent investment in medication adherence company MedMinder.
Alignment Healthcare, an insurtech startup, has launched its IPO and plans to price its individual shares between $17 and $19. The company offers Medicare Advantage plans and says it uses predictive analytics technology to pinpoint seniors’ care needs.
With the extension to its Series A financing, XyloCor plans a clinical trial testing its gene therapy as an adjunct to coronary artery bypass graft surgery. A study in refractory angina is already underway.
Komodo, a data analytics startup building out information on patient encounters and outcomes, raised $220 million in funding. It plans to use the funds to build out its platform and further integrate it in users’ workflows.
AstraZeneca reported that its Covid-19 vaccine was 79% effective at preventing severe infection and 100% effective at preventing hospitalization. The company expects to file a submission seeking FDA emergency use authorization in coming weeks.
It may seem intuitive to avoid telehealth or remote care to avoid increased liability and malpractice exposure. But remote behavioral health assessment tools, real-time data-driven insights, and adaptive treatment plans are actually the things that protect clinicians from civil liability in instances of patient suicide.
The American Hospital Association is urging the Justice Department to thoroughly review UnitedHealth’s intended acquisition of Change Healthcare. The transaction would reduce competition in the health IT arena and result in higher prices and lower quality of care, the hospital group says.
The Covid-19 pandemic has decimated hospital finances, and as a result, rural providers are forced to make key IT spending decisions with limited dollars. Here is a snapshot of how they will prioritize those dollars this year and the federal support they need to survive… Read More »Rural hospitals contend with an expensive shift to digital amid shrinking margins
Automation expands the capacity of care teams, allowing providers to accomplish more with less. As a result, automation can offer an unbiased and personalized mechanism to reach patients in the manner that best suits them.
Reflecting on lessons learned from the pandemic, healthcare leaders pointed to the lack of coordination and glaring health disparities that hampered the U.S. pandemic response. Going forward, they hope to see future change in the healthcare system.
Scientists at The Ohio State University are developing a cell therapy intended to regrow brain tissue damaged from ischemic stroke. Results from a study in mice were published in the journal Science Advances.
Viz.AI, a San Francisco-based care coordination startup, raised $71 million in series C funding. The company plans to use the funds to build out its platform beyond coordinating care for stroke.
In an interview with MedCity News, Hospital Sisters Health System’s Director of Quality Bill Cox discussed the types of technology the 15-hospital system is using to enhance patient safety and why a systemwide strategy and culture shift is necessary for successful IT deployment.
With widespread vaccine shortages alongside continuing deaths from Covid-19, we must act now to leverage existing technology in order to improve the distribution process.
There is a growing demand for centralized care for Covid-19 long-haulers — that is, patients who had Covid-19 and recovered but continue to experience symptoms. Health systems are setting up clinics specifically for this patient population, which comes with its own set of opportunities and… Read More »Covid-19 long-hauler clinics offer a ‘medical home’ for patients on uncharted journey